Skip to main content
Premium Trial:

Request an Annual Quote

NSF, USDA to Award $15M in FY 2004 Microbial Sequencing Grants

NEW YORK, Sept. 22 (GenomeWeb News) - An interagency effort between the National Science Foundation and the US Department of Agriculture will award approximately $15 million in microbial sequencing grants in fiscal year 2004, according to a recent NSF program solicitation.

NSF and the USDA's Cooperative State Research, Education, and Extension Service are seeking research proposals to support high-throughput sequencing of the genomes of viruses, bacteria, archaea, fungi, oomycetes, protists, and nematodes "that are either of fundamental biological interest, are important to the national interest, to the productivity and sustainability of agriculture and forestry, or to the safety and quality of the nation's food supply." 

Around 20-30 awards will be granted, with most awards ranging between $100,000 and $2.5 million, for periods of up to three years, the agencies said. NSF will contribute around $10 million of the total funding, while USDA will provide $5 million.

Letters of intent are due on Oct. 15, and the proposal deadline is Dec. 15.

The full solicitation is available here.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.